Clinical risk factors and evaluation of the risk of osteoporosis in clinical practice : Dossier thématique: L'ostéoporose = Theme topic: OsteoporosisMCCLUNG, Michael R.Annales de médecine interne (Paris). 2000, Vol 151, Num 5, pp 392-398, issn 0003-410XArticle

Pharmacologic therapy for the treatment and prevention of osteoporosis : OsteoporosisMCCLUNG, Betsy; MCCLUNG, Michael.The Nursing clinics of North-America. 2001, Vol 36, Num 3, issn 0029-6465, viii, 433-440 [9 p.]Article

Comparison of weekly treatment of postmenopausal osteoporosis with alendronate Versus risedronate over two yearsBONNICK, Sydney; SAAG, Kenneth G; DE PAPP, Anne E et al.The Journal of clinical endocrinology and metabolism. 2006, Vol 91, Num 7, pp 2631-2637, issn 0021-972X, 7 p.Article

Excretion of sweat and urine pyridinoline crosslinks in healthy controls and subjects with established metabolic bone diseaseSARNO, Mark; SARNO, Laura; MILLER, Paul et al.Clinical chemistry and laboratory medicine. 2001, Vol 39, Num 3, pp 223-228, issn 1434-6621Article

BisphosphonatesMCCLUNG, Michael R.Endocrinology and metabolism clinics of North America. 2003, Vol 32, Num 1, issn 0889-8529, ix, 253-271 [20 p.]Article

Bone density recovery after depot medroxyprogesterone acetate injectable contraception useKAUNITZ, Andrew M; ARIAS, Raquel; MCCLUNG, Michael et al.Contraception (Stoneham). 2008, Vol 77, Num 2, pp 67-76, issn 0010-7824, 10 p.Article

Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronateMCCLUNG, Michael; RECKER, Robert; MILLER, Paul et al.Bone (New York, NY). 2007, Vol 41, Num 1, pp 122-128, issn 8756-3282, 7 p.Article

Arzoxifene for Prevention of Fractures and Invasive Breast Cancer in Postmenopausal WomenCUMMINGS, Steven R; MCCLUNG, Michael; CHRISTIANSEN, Claus et al.Journal of bone and mineral research (Print). 2011, Vol 26, Num 2, pp 397-404, issn 0884-0431, 8 p.Article

Zoledronic Acid for the Prevention of Bone Loss in Postmenopausal Women With Low Bone Mass: A Randomized Controlled TrialMCCLUNG, Michael; MILLER, Paul; RECKNOR, Chris et al.Obstetrics and gynecology (New York. 1953). 2009, Vol 114, Num 5, pp 999-1007, issn 0029-7844, 9 p.Article

Treatment with once-weekly alendronate 70 mg compared with once-weekly risedronate 35 mg in women with postmenopausal osteoporosis: A randomized double-blind studyROSEN, Clifford J; HOCHBERG, Marc C; DE PAPP, Anne E et al.Journal of bone and mineral research (Print). 2005, Vol 20, Num 1, pp 141-151, issn 0884-0431, 11 p.Article

The long-term effect of specific type II 5α-reductase inhibition with finasteride on bone mineral density in men: Results of a 4-year placebo controlled trialMATSUMOTO, Alvin M; TENOVER, Lisa; ZHANG, Gang K et al.The Journal of urology. 2002, Vol 167, Num 5, pp 2105-2108, issn 0022-5347Article

Prevention of bone loss with tibolone in postmenopausal women : Results of two randomized, double-blind, placebo-controlled, dose-finding studiesGALLAGHER, J. C; BAYLINK, David J; FREEMAN, Ruth et al.The Journal of clinical endocrinology and metabolism. 2001, Vol 86, Num 10, pp 4717-4726, issn 0021-972XArticle

Do current management strategies and guidelines adequately address fracture risk?MCCLUNG, Michael R.Bone (New York, NY). 2006, Vol 38, Num 2, issn 8756-3282, S13-S17, SUP2Conference Paper

Efficacy and safety of monthly oral ibandronate in the prevention of postmenopausal bone lossMCCLUNG, Michael R; BOLOGNESE, Michael A; SEDARATI, Farhad et al.Bone (New York, NY). 2009, Vol 44, Num 3, pp 418-422, issn 8756-3282, 5 p.Article

Bone mineral density in women aged 25-35 years receiving depot medroxyprogesterone acetate : recovery following discontinuationKAUNITZ, Andrew M; MILLER, Paul D; MONTGOMERY RICE, Valerie et al.Contraception (Stoneham). 2006, Vol 74, Num 2, pp 90-99, issn 0010-7824, 10 p.Article

Safety and efficacy of risedronate in reducing fracture risk in osteoporotic women aged 80 and older: Implications for the use of antiresorptive agents in the old and oldest oldBOONEN, Steven; MCCLUNG, Michael R; EASTELL, Richard et al.Journal of the American Geriatrics Society. 2004, Vol 52, Num 11, pp 1832-1839, issn 0002-8614, 8 p.Article

Effects of Pioglitazone on Bone in Postmenopausal Women With Impaired Fasting Glucose or Impaired Glucose Tolerance: A Randomized, Double-Blind, Placebo-Controlled StudyBONE, Henry G; LINDSAY, Robert; MCCLUNG, Michael R et al.The Journal of clinical endocrinology and metabolism. 2013, Vol 98, Num 12, pp 4691-4701, issn 0021-972X, 11 p.Article

Femoral strength in osteoporotic women treated with teriparatide or alendronateKEAVENY, Tony M; MCCLUNG, Michael R; XIAOHAI WAN et al.Bone (New York, NY). 2012, Vol 50, Num 1, pp 165-170, issn 8756-3282, 6 p.Article

Assessment of mortality in patients enrolled in a risedronate clinical trial program: A retrospective cohort studySTEINBUCH, Michael; D'AGOSTINO, Ralph B; MANDEL, Jack S et al.Regulatory toxicology and pharmacology (Print). 2002, Vol 35, Num 3, pp 320-326, issn 0273-2300Article

Effect of Denosumab on Bone Mineral Density and Biochemical Markers of Bone Turnover: Six-Year Results of a Phase 2 Clinical TrialMILLER, Paul D; WAGMAN, Rachel B; PEACOCK, Munro et al.The Journal of clinical endocrinology and metabolism. 2011, Vol 96, Num 2, pp 394-402, issn 0021-972X, 9 p.Article

Improvements in hip trabecular, subcortical, and cortical density and mass in postmenopausal women with osteoporosis treated with denosumabGENANT, Harry K; LIBANATI, Cesar; RADCLIFFE, Hoi-Shen et al.Bone (New York, NY). 2013, Vol 56, Num 2, pp 482-488, issn 8756-3282, 7 p.Article

Odanacatib, a Cathepsin-K Inhibitor for Osteoporosis: A Two-Year Study in Postmenopausal Women With Low Bone DensityBONE, Henry G; MCCLUNG, Michael R; ROUX, Christian et al.Journal of bone and mineral research (Print). 2010, Vol 25, Num 5, pp 937-947, issn 0884-0431, 11 p.Article

Official Positions of the International Society for Clinical DensitometryLEWIECKI, E. Michael; WATTS, Nelson B; MCCLUNG, Michael R et al.The Journal of clinical endocrinology and metabolism. 2004, Vol 89, Num 8, pp 3651-3655, issn 0021-972X, 5 p.Article

Effect of risedronate on the risk of hip fracture in elderly womenMCCLUNG, Michael R; GEUSENS, Piet; MEUNIER, Pierre J et al.The New England journal of medicine. 2001, Vol 344, Num 5, pp 333-340, issn 0028-4793Article

Effects of Denosumab on Bone Turnover Markers in Postmenopausal OsteoporosisEASTELL, Richard; CHRISTIANSEN, Claus; WANG, Andrea et al.Journal of bone and mineral research (Print). 2011, Vol 26, Num 3, pp 530-537, issn 0884-0431, 8 p.Article